After obtaining a key patent in Europe, Anew Medical's stock price soared by 130%
In the past 52 weeks, the stock has traded in a range of $1.54 to $13.1. There has been significant volatility, so please be aware of the risks
Anew Medical, Inc. (WENA) stock soared over 130% on Wednesday morning after the company announced it had secured a key patent in Europe for its secreted Klotho gene sequence and gene delivery system.
WENA is currently trading at $3.82, up $2.17 or 131.5%, with a massive trading volume of 44 million shares, far exceeding the Nasdaq average trading volume of 217,000 shares. The stock opened at $4.55 after closing at $1.65 on Tuesday. Over the past 52 weeks, the stock has traded in a range of $1.54 to $13.1.
Anew Medical announced that it has been granted a patent EP3377091B1 in Europe for the application of ANEW secreted Klotho gene sequence and gene delivery system in the treatment of cognitive decline, memory loss, dementia, and other neurodegenerative diseases.
This key intellectual property asset has been exclusively licensed to ANEW by the Autonomous University of Barcelona (Universitat Autonoma de Barcelona, UAB) and the Catalan Institution for Research and Advanced Studies (Institucio Catalana de Recerca i Estudis Avançats, ICREA).
Source: rttnews